-
Something wrong with this record ?
Performance of Seven SARS-CoV-2 Self-Tests Based on Saliva, Anterior Nasal and Nasopharyngeal Swabs Corrected for Infectiousness in Real-Life Conditions: A Cross-Sectional Test Accuracy Study
M. Homza, H. Zelena, J. Janosek, H. Tomaskova, E. Jezo, A. Kloudova, J. Mrazek, V. Murinova, R. Madar
Language English Country Switzerland
Document type Journal Article
NLK
Directory of Open Access Journals
from 2011
PubMed Central
from 2011
Europe PubMed Central
from 2011
ProQuest Central
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Open Access Digital Library
from 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2011
- Publication type
- Journal Article MeSH
Many studies reported good performance of nasopharyngeal swab-based antigen tests for detecting SARS-CoV-2-positive individuals; however, studies independently evaluating the quality of antigen tests utilizing anterior nasal swabs or saliva swabs are still rare, although such tests are widely used for mass testing. In our study, sensitivities, specificities and predictive values of seven antigen tests for detection of SARS-CoV-2 (one using nasopharyngeal swabs, two using anterior nasal swabs and four using saliva) were evaluated. In a setting of a high-capacity testing center, nasopharyngeal swabs for quantitative PCR (qPCR) were taken and, at the same time, antigen testing was performed in accordance with manufacturers' instructions for the respective tests. In samples where qPCR and antigen tests yielded different results, virus culture was performed to evaluate the presence of the viable virus. Sensitivities and specificities of individual tests were calculated using both qPCR and qPCR corrected for viability as the reference. In addition, calculations were also performed for data categorized according to the cycle threshold and symptomatic status. The test using nasopharyngeal swabs yielded the best results (sensitivity of 80.6% relative to PCR and 91.2% when corrected for viability) while none of the remaining tests (anterior nasal swab or saliva-based tests) came even close to the WHO criteria for overall sensitivity. Hence, we advise caution when using antigen tests with alternative sampling methods without independent validation.
Hospital Karvina Raj Vydmuchov 399 734 01 Karvina Czech Republic
Institute of Public Health Ostrava Partyzánské náměstí 7 702 00 Ostrava Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21024065
- 003
- CZ-PrNML
- 005
- 20211013134050.0
- 007
- ta
- 008
- 211006s2021 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/diagnostics11091567 $2 doi
- 035 __
- $a (PubMed)34573909
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Homza, Miroslav $u Hospital Karvina-Raj, Vydmuchov 399, 734 01 Karvina, Czech Republic $u Department of Internal Medicine, Faculty of Medicine, University of Ostrava, Syllabova 19, 703 00 Ostrava, Czech Republic
- 245 10
- $a Performance of Seven SARS-CoV-2 Self-Tests Based on Saliva, Anterior Nasal and Nasopharyngeal Swabs Corrected for Infectiousness in Real-Life Conditions: A Cross-Sectional Test Accuracy Study / $c M. Homza, H. Zelena, J. Janosek, H. Tomaskova, E. Jezo, A. Kloudova, J. Mrazek, V. Murinova, R. Madar
- 520 9_
- $a Many studies reported good performance of nasopharyngeal swab-based antigen tests for detecting SARS-CoV-2-positive individuals; however, studies independently evaluating the quality of antigen tests utilizing anterior nasal swabs or saliva swabs are still rare, although such tests are widely used for mass testing. In our study, sensitivities, specificities and predictive values of seven antigen tests for detection of SARS-CoV-2 (one using nasopharyngeal swabs, two using anterior nasal swabs and four using saliva) were evaluated. In a setting of a high-capacity testing center, nasopharyngeal swabs for quantitative PCR (qPCR) were taken and, at the same time, antigen testing was performed in accordance with manufacturers' instructions for the respective tests. In samples where qPCR and antigen tests yielded different results, virus culture was performed to evaluate the presence of the viable virus. Sensitivities and specificities of individual tests were calculated using both qPCR and qPCR corrected for viability as the reference. In addition, calculations were also performed for data categorized according to the cycle threshold and symptomatic status. The test using nasopharyngeal swabs yielded the best results (sensitivity of 80.6% relative to PCR and 91.2% when corrected for viability) while none of the remaining tests (anterior nasal swab or saliva-based tests) came even close to the WHO criteria for overall sensitivity. Hence, we advise caution when using antigen tests with alternative sampling methods without independent validation.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Zelena, Hana $u Institute of Public Health Ostrava, Partyzánské náměstí 7, 702 00 Ostrava, Czech Republic
- 700 1_
- $a Janosek, Jaroslav $u Center for Health Research, Faculty of Medicine, University of Ostrava, Syllabova 19, 703 00 Ostrava, Czech Republic
- 700 1_
- $a Tomaskova, Hana $u Institute of Public Health Ostrava, Partyzánské náměstí 7, 702 00 Ostrava, Czech Republic $u Department of Epidemiology and Public Health, Faculty of Medicine, University of Ostrava, Syllabova 19, 703 00 Ostrava, Czech Republic
- 700 1_
- $a Jezo, Eduard $u Institute of Public Health Ostrava, Partyzánské náměstí 7, 702 00 Ostrava, Czech Republic
- 700 1_
- $a Kloudova, Alena $u Institute of Public Health Ostrava, Partyzánské náměstí 7, 702 00 Ostrava, Czech Republic
- 700 1_
- $a Mrazek, Jakub $u Institute of Public Health Ostrava, Partyzánské náměstí 7, 702 00 Ostrava, Czech Republic
- 700 1_
- $a Murinova, Vera $u Hospital Karvina-Raj, Vydmuchov 399, 734 01 Karvina, Czech Republic
- 700 1_
- $a Madar, Rastislav $u Department of Epidemiology and Public Health, Faculty of Medicine, University of Ostrava, Syllabova 19, 703 00 Ostrava, Czech Republic
- 773 0_
- $w MED00195450 $t Diagnostics (Basel, Switzerland) $x 2075-4418 $g Roč. 11, č. 9 (2021)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34573909 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20211006 $b ABA008
- 991 __
- $a 20211013134047 $b ABA008
- 999 __
- $a ind $b bmc $g 1708181 $s 1144562
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 11 $c 9 $e 20210828 $i 2075-4418 $m Diagnostics $n Diagnostics $x MED00195450
- LZP __
- $a Pubmed-20211006